Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Labetuzumab [USAN:INN]
RN: 219649-07-7
UNII: EFE6X5M3UY

Note

  • Humanized monoclonal antibody to carcinoembryonic antigen that inhibits tumor growth; used in radioimmunotherapy.
 

Classification Codes

  • Antineoplastic Agents
  • Antineoplastic Agents, Immunological
  • Monoclonal Antibody
  • Treatment of Colorectal Cancer (Humanized Monoclonal Antibody hMN-14 Targeting CEA-Positive Cancers)
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Labetuzumab
  • Labetuzumab [USAN:INN]

Synonyms

  • CEA-Cide
  • hMN-14
  • IMMU-100
  • Immunoglobulin G, anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 gamma-chain), disulfide with human-mouse monoclonal hMN-14 kappa-chain, dimer
  • Labetuzumab
  • MAb hMN14
  • Monoclonal antibody hMN-14
  • UNII-EFE6X5M3UY

Systematic Name

  • Immunoglobulin G, anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 gamma-chain), disulfide with human-mouse monoclonal hMN-14 kappa-chain, dimer

Registry Numbers

CAS Registry Number

  • 219649-07-7

FDA UNII

  • EFE6X5M3UY

System Generated Number

  • 0219649077